AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Cyprium Metals Limited

AUD 0.48 -$0.10 (-17.24%)
ASX · 15 Sep 2026 06:10 UTC
Previous Close
AUD 0.49
Day Range
AUD 0.47AUD 0.5
Year Range
AUD 0.28AUD 0.64
Market Cap
85.24M
AVG Volume
993.62K
Trailing/Forward PE
-8.08/32
PEG ratio
0.05
Dividend Yield
-
Next Earnings Date
2026-09-16
Primary Exchange
Australian Securities ExchangeAU
Revenue (AUD)
0200K400K600K800K21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
CYM.AX Revenue (AUD) by quarter
PeriodRevenue (AUD)
25 Q40
25 Q20
24 Q40
24 Q20
23 Q40
23 Q2799K
22 Q40
22 Q20
21 Q424K
21 Q20
Net Income (AUD)
-20M-15M-10M-5M021 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
CYM.AX Net Income (AUD) by quarter
PeriodNet Income (AUD)
25 Q4-8.1M
25 Q2-8.9M
24 Q4-17.52M
24 Q2-12.59M
23 Q4-8.59M
23 Q2-10.98M
22 Q4-9.63M
22 Q2-17.84M
21 Q4-15.74M
21 Q2-10.93M
Operating Income (AUD)
-20M-15M-10M-5M021 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
CYM.AX Operating Income (AUD) by quarter
PeriodOperating Income (AUD)
25 Q4-16.61M
25 Q2-8.42M
24 Q4-13.26M
24 Q2-9.73M
23 Q4-10.41M
23 Q2-8.49M
22 Q4-10.39M
22 Q2-17.86M
21 Q4-16.28M
21 Q2-10.04M
EBITDA (AUD)
-20M-15M-10M-5M021 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
CYM.AX EBITDA (AUD) by quarter
PeriodEBITDA (AUD)
25 Q4-16.19M
25 Q2-7.13M
24 Q4-13.26M
24 Q2-9.95M
23 Q4-7.94M
23 Q2-7.92M
22 Q4-10.25M
22 Q2-17.03M
21 Q4-14.87M
21 Q2-9.49M
Cash Flows (AUD)
-40M-30M-20M-10M021 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
CYM.AX Cash Flows (AUD) by quarter
PeriodCash Flows (AUD)
25 Q4-14.96M
25 Q2-14.98M
24 Q4-16.8K
24 Q2-14.99K
23 Q4-12.93K
23 Q2-6.49M
22 Q4-18.24M
22 Q2-22.38M
21 Q4-25.13M
21 Q2-32.11M
EPS (AUD)
-0.3-0.2-0.1-021 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
CYM.AX EPS (AUD) by quarter
PeriodEPS (AUD)
25 Q4-0.02
25 Q2-0.04
24 Q4-0.11
24 Q2-0.08
23 Q4-0.07
23 Q2-0.14
22 Q4-0.12
22 Q2-0.29
21 Q4-0.25
21 Q2-0.3
Expenses (AUD)
010M20M30M40MSG&ACapex21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
CYM.AX Expenses (AUD) by quarter
PeriodExpenses (AUD)
25 Q417.22M
25 Q210.12M
24 Q413.27M
24 Q29.74M
23 Q410.99M
23 Q29.91M
22 Q415.39M
22 Q227.66M
21 Q427.92M
21 Q236.05M
Cash & Debt (AUD)
020M40M60M80MCashLong Term DebtShort Term Debt21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
CYM.AX Cash & Debt (AUD) by quarter
PeriodCash & Debt (AUD)
25 Q476.24M
25 Q213.66M
24 Q414.21M
24 Q27.33M
23 Q422.59M
23 Q23.6M
22 Q41.69M
22 Q22.92M
21 Q425.47M
21 Q250.62M
Debt ratios
-2-101221 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
CYM.AX Debt ratios by quarter
PeriodDebt ratios
25 Q40.33
25 Q2-1.22
24 Q4-1.17
24 Q2-1.24
23 Q4-0.84
23 Q2-0.83
22 Q4-0.77
22 Q2-0.88
21 Q4-0.52
21 Q21.14
Margins
-6000%-4000%-2000%0%2000%14 Q415 Q215 Q416 Q216 Q417 Q217 Q420 Q421 Q423 Q2
CYM.AX Margins by quarter
PeriodMargins
23 Q2-5.38%
21 Q4-5925%
20 Q480.46%
17 Q41855.56%
17 Q2100%
16 Q4100%
16 Q2100%
15 Q4100%
15 Q2100%
14 Q4100%
Return on Capital
-30%-20%-10%0%21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
CYM.AX Return on Capital by quarter
PeriodReturn on Capital
25 Q4-5.25%
25 Q2-10.42%
24 Q4-20.63%
24 Q2-15.58%
23 Q4-10.27%
23 Q2-17.68%
22 Q4-13.44%
22 Q2-27.78%
21 Q4-20.03%
21 Q2-11.96%
Shares Outstanding
0200M400M600M21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
CYM.AX Shares Outstanding by quarter
PeriodShares Outstanding
25 Q4492.82M
25 Q2208.27M
24 Q4153.69M
24 Q2151.68M
23 Q4121.06M
23 Q280.51M
22 Q480.51M
22 Q262.28M
21 Q462.28M
21 Q236.63M
Book Value Per Share (AUD)
012321 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
CYM.AX Book Value Per Share (AUD) by quarter
PeriodBook Value Per Share (AUD)
25 Q40.31
25 Q20.41
24 Q40.55
24 Q20.53
23 Q40.69
23 Q20.77
22 Q40.89
22 Q21.03
21 Q41.26
21 Q22.5
Total Assets (AUD)
0100M200M300M21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
CYM.AX Total Assets (AUD) by quarter
PeriodTotal Assets (AUD)
25 Q4259.76M
25 Q2186.44M
24 Q4183.22M
24 Q2173.06M
23 Q4182.93M
23 Q2160.55M
22 Q4154.5M
22 Q2153.09M
21 Q4173.91M
21 Q2173.19M
PE Ratio
0.250.50.7511.25med 0.79Apr 11Jun 11Aug 11Oct 11Dec 11Jan 12Mar 12
CYM.AX PE Ratio by quarter
PeriodPE Ratio
Mar 120.53
Mar 120.61
Mar 120.69
Mar 120.76
Feb 120.84
Feb 120.53
Feb 120.61
Feb 120.46
Jan 120.53
Jan 120.53
Jan 120.38
Jan 120.61
Dec 110.69
Dec 110.76
Dec 110.91
Dec 110.99
Dec 111.07
Nov 110.99
Nov 110.91
Nov 110.91
Nov 110.99
Oct 111.14
Oct 111.14
Oct 111.07
Oct 111.07
Sep 111.07
Sep 110.47
Sep 110.59
Sep 110.59
Sep 110.5
Aug 110.5
Aug 110.53
Aug 110.59
Aug 110.53
Jul 110.65
Jul 110.65
Jul 110.72
Jul 110.84
Jul 110.81
Jun 110.78
Jun 110.78
Jun 110.9
Jun 110.9
May 110.87
May 110.9
May 110.97
May 110.93
Apr 111.06
Apr 111.09
Apr 111.06
Apr 111.18
Apr 111.09
Free Cash Flow Yield
-100%-75%-50%-25%0%med -16.63%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
CYM.AX Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-12.29%
Sep 26-11.7%
Sep 26-11.48%
Aug 26-11.06%
Aug 26-11.16%
Aug 26-12.41%
Aug 26-12.54%
Jul 26-13.67%
Jul 26-14.48%
Jul 26-14.31%
Jul 26-14.15%
Jul 26-13.37%
Jun 26-14.84%
Jun 26-16.01%
Jun 26-16.22%
Jun 26-16.67%
May 26-14.84%
May 26-15.4%
May 26-13.52%
May 26-14.66%
May 26-16.67%
Apr 26-16.44%
Apr 26-17.13%
Apr 26-19.01%
Apr 26-16.67%
Mar 26-20.04%
Mar 26-21.87%
Mar 26-17.6%
Mar 26-16.04%
Feb 26-13.12%
Feb 26-15.52%
Feb 26-15.03%
Feb 26-15.69%
Jan 26-12.79%
Jan 26-13.61%
Jan 26-12.89%
Jan 26-13.61%
Jan 26-12.44%
Dec 25-16.59%
Dec 25-16.4%
Dec 25-18.04%
Dec 25-17.18%
Nov 25-18.74%
Nov 25-22.2%
Nov 25-20.62%
Nov 25-20.04%
Oct 25-18.04%
Oct 25-20.62%
Oct 25-18.99%
Oct 25-17.18%
Oct 25-15.69%
Sep 25-11.5%
Sep 25-14.67%
Sep 25-14.67%
Sep 25-15.19%
Aug 25-13.85%
Aug 25-13.85%
Aug 25-14.8%
Aug 25-13.85%
Aug 25-15.33%
Jul 25-12.63%
Jul 25-13.85%
Jul 25-12.63%
Jul 25-13.85%
Jun 25-14.31%
Jun 25-15.9%
Jun 25-14.8%
Jun 25-15.9%
May 25-18.67%
May 25-18.67%
May 25-17.17%
May 25-20.44%
May 25-21.47%
Apr 25-21.47%
Apr 25-23.85%
Apr 25-23.85%
Apr 25-23.85%
Mar 25-78.46%
Mar 25-86.72%
Mar 25-96.92%
Mar 25-82.39%
Feb 25-82.39%
Feb 25-78.46%
Feb 25-74.89%
Feb 25-65.91%
Jan 25-65.91%
Jan 25-61.03%
Jan 25-61.03%
Jan 25-63.37%
Jan 25-65.91%
Dec 24-61.03%
Dec 24-78.46%
Dec 24-65.91%
Dec 24-61.03%
Nov 24-91.54%
Nov 24-91.54%
Nov 24-78.46%
Nov 24-82.39%
Nov 24-63.37%
Oct 24-56.82%
Price to Sales
020406080med 46.78Jan 24Apr 24Aug 24Nov 24Feb 25Jun 25Sep 25
CYM.AX Price to Sales by quarter
PeriodPrice to Sales
Sep 2571.17
Sep 2555.78
Sep 2555.78
Sep 2553.86
Aug 2559.09
Aug 2559.09
Aug 2555.27
Aug 2559.09
Aug 2553.37
Jul 2564.8
Jul 2559.09
Jul 2564.8
Jul 2559.09
Jun 2557.18
Jun 2551.46
Jun 2555.27
Jun 2551.46
May 2543.84
May 2543.84
May 2547.65
May 2540.03
May 2538.12
Apr 2538.12
Apr 2534.31
Apr 2534.31
Apr 2534.31
Mar 2539.5
Mar 2535.74
Mar 2531.98
Mar 2537.62
Feb 2537.62
Feb 2539.5
Feb 2541.38
Feb 2547.03
Jan 2547.03
Jan 2550.79
Jan 2550.79
Jan 2548.91
Jan 2547.03
Dec 2450.79
Dec 2439.5
Dec 2447.03
Dec 2450.79
Nov 2433.86
Nov 2433.86
Nov 2439.5
Nov 2437.62
Nov 2448.91
Oct 2454.55
Oct 2458.31
Oct 2460.19
Oct 2462.08
Sep 2448.04
Sep 2446.54
Sep 2442.04
Sep 2442.04
Aug 2451.04
Aug 2445.04
Aug 2446.54
Aug 2452.55
Aug 2455.55
Jul 2463.06
Jul 2455.55
Jul 2467.56
Jul 2475.07
Jun 2467.56
Jun 2466.06
Jun 2466.06
Jun 2470.56
May 2460.05
May 2461.56
May 2454.05
May 2454.05
May 2457.05
Apr 2448.04
Apr 2442.04
Apr 2443.54
Apr 2425.52
Mar 2418.42
Mar 2419.39
Mar 2418.42
Mar 2416.48
Mar 2412.6
Feb 2416.48
Feb 2417.45
Feb 2418.42
Feb 2421.32
Jan 2425.2
Jan 2421.32
Jan 2425.2
Jan 2426.17
Dec 2329.08
Dec 2325.2
Dec 2327.14
Dec 2326.17
Dec 2328.11
Nov 2328.11
Nov 2326.17
Nov 2325.2
Nov 2326.17
Price to Book
00.511.52med 0.8Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
CYM.AX Price to Book by quarter
PeriodPrice to Book
Sep 261.58
Sep 261.66
Sep 261.69
Aug 261.76
Aug 261.74
Aug 261.57
Aug 261.55
Jul 261.42
Jul 261.34
Jul 261.36
Jul 261.37
Jul 261.45
Jun 261.31
Jun 261.21
Jun 261.2
Jun 261.17
May 261.31
May 261.26
May 261.44
May 261.33
May 261.17
Apr 261.18
Apr 261.13
Apr 261.02
Apr 261.17
Mar 260.88
Mar 260.8
Mar 261
Mar 261.1
Feb 261.34
Feb 261.13
Feb 261.17
Feb 261.12
Jan 261.38
Jan 261.29
Jan 261.36
Jan 261.29
Jan 261.41
Dec 251.06
Dec 251.07
Dec 250.97
Dec 251.02
Nov 250.94
Nov 250.79
Nov 250.85
Nov 250.88
Oct 250.97
Oct 250.85
Oct 250.93
Oct 251.02
Oct 251.12
Sep 250.67
Sep 250.52
Sep 250.52
Sep 250.51
Aug 250.56
Aug 250.56
Aug 250.52
Aug 250.56
Aug 250.5
Jul 250.61
Jul 250.56
Jul 250.61
Jul 250.56
Jun 250.54
Jun 250.48
Jun 250.52
Jun 250.48
May 250.41
May 250.41
May 250.45
May 250.38
May 250.36
Apr 250.36
Apr 250.32
Apr 250.32
Apr 250.32
Mar 250.39
Mar 250.35
Mar 250.32
Mar 250.37
Feb 250.37
Feb 250.39
Feb 250.41
Feb 250.47
Jan 250.47
Jan 250.5
Jan 250.5
Jan 250.48
Jan 250.47
Dec 240.5
Dec 240.39
Dec 240.47
Dec 240.5
Nov 240.33
Nov 240.33
Nov 240.39
Nov 240.37
Nov 240.48
Oct 240.54
Cyprium Metals Limited
CYM.AX
Stockpicker

Video analysis: CYM.AX

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: CYM.AX

SpaceX shares fall after Starship test launch aborted by engine ignition failure

proactiveinvestors.com · 17 Jul 2026

SpaceX shares fall after Starship test launch aborted by engine ignition failure

SpaceX Corp (NASDAQ:SPCX) shares fell on Friday for a fifth consecutive session after the company's Starship rocket automatically aborted a test launch...

Cyprium uncovers extensive copper mineralisation in Nifty waste dump

proactiveinvestors.com · 9 Jul 2026

Cyprium uncovers extensive copper mineralisation in Nifty waste dump

Cyprium Metals Ltd (ASX:CYM, OTCQB:CYPMF) has identified extensive copper mineralisation within the historical waste dump at its Nifty Copper Complex in...

AstraZeneca's £19bn blow as Wainua heart drug fails key late-stage trial

proactiveinvestors.com · 9 Jul 2026

AstraZeneca's £19bn blow as Wainua heart drug fails key late-stage trial

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) shares fell 9.55% in early trading, wiping £19 billion from the company's valuation, after its Wainua drug failed a...

Cyprium Metals eyes first copper by Sept 2026 - ICYMI

proactiveinvestors.com · 30 Jun 2026

Cyprium Metals eyes first copper by Sept 2026 - ICYMI

Cyprium Metals Ltd (ASX:CYM, OTCQB:CYPMF) last week outlined strong quarterly progress at its Nifty Copper Complex, with the company remaining on track for...

IBM quantum foundry plan adds to long-term hardware strategy: Wedbush

proactiveinvestors.com · 26 Jun 2026

IBM quantum foundry plan adds to long-term hardware strategy: Wedbush

International Business Machines Corp (NYSE:IBM) unveiled new semiconductor technology featuring a sub-1 nanometer chip architecture, which Wedbush analysts...

Cyprium Metals strengthens Nifty restart team with CTO appointment

proactiveinvestors.com · 26 Jun 2026

Cyprium Metals strengthens Nifty restart team with CTO appointment

Cyprium Metals Ltd (ASX:CYM, OTCQB:CYPMF) has appointed experienced mining engineer and resources executive Christofer Catania as chief technical officer as...

The next big AI titan could be the company that makes your TV and smartphone

proactiveinvestors.com · 26 Jun 2026

The next big AI titan could be the company that makes your TV and smartphone

We have spent two years watching the AI build-out through an American lens. Nvidia Corp (NASDAQ:NVDA, XETRA:NVD), Microsoft Corp (NASDAQ:MSFT), OpenAI...

Cyprium Metals moves Nifty Copper Complex closer to restart as acid deliveries resume after 20 years

proactiveinvestors.com · 25 Jun 2026

Cyprium Metals moves Nifty Copper Complex closer to restart as acid deliveries resume after 20 years

Cyprium Metals Ltd (ASX:CYM, OTCQB:CYPMF) has advanced the Phase 1 Cathode Restart at its Nifty Copper Complex in Western Australia, with work shifting from...

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.